Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
RMD Open|September 17, 2021
A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritisKulveer Mankia, Heidi Siddle, Andrea Di Matteo, et al.
Rheumatology (Oxford, England)|January 8, 2021
In anti-CCP+ at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritisAndrea Di Matteo, Kulveer Mankia, Jacqueline L Nam, et al.
RMD Open|April 10, 2024
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody testAndrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, et al.
Annals of the Rheumatic Diseases|October 10, 2018
Identification of a distinct imaging phenotype may improve the management of palindromic rheumatismKulveer Mankia, Maria-Antonietta D'Agostino, Richard J Wakefield, et al.
Annals of the Rheumatic Diseases|May 6, 2020
Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitisAndrea Di Matteo, Kulveer Mankia, Laurence Duquenne, et al.
Arthritis Research & Therapy|January 19, 2022
Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational studyLeticia Garcia-Montoya, Jacqueline L Nam, Laurence Duquenne, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritisZijian Cheng, Thuy Do, Kulveer Mankia, et al.
Annals of the Rheumatic Diseases|March 11, 2026
Quantitative MRI tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individualsKerem Abacar, Yuya Tabuchi, Andrea Di Matteo, et al.
Rheumatology Advances in Practice|March 18, 2024
'What is my risk really?': a qualitative exploration of preventive interventions among individuals at risk of rheumatoid arthritisLara S Chapman, Heidi J Siddle, Stefan Serban, et al.
Rheumatology (Oxford, England)|December 10, 2024
A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary careHeidi J Siddle, Michelle Wilson, Jacqueline L Nam, et al.
Pageof 8